Cost Effectiveness of Ventricular Tachycardia Ablation Versus Escalation of Antiarrhythmic Drug Therapy The VANISH Trial

Abstract

OBJECTIVES: This analysis uses the data from the randomized controlled trial to assess the cost effectiveness of catheter ablation (n = 132) versus escalated antiarrhythmic therapy (n = 127). BACKGROUND: For survivors of myocardial infarction with implantable cardioverter-defibrillator shocks despite antiarrhythmic drugs, the VANISH (Ventricular Tachycardia Ablation Versus Escalated Antiarrhythmic Drug Therapy in Ischemic Heart Disease) trial …

Authors

Coyle K; Coyle D; Nault I; Parkash R; Healey JS; Gray CJ; Gardner MJ; Sterns LD; Essebag V; Hruczkowski T

Journal

JACC Clinical Electrophysiology, Vol. 4, No. 5, pp. 660–668

Publisher

Elsevier

Publication Date

5 2018

DOI

10.1016/j.jacep.2018.01.007

ISSN

2405-500X

Associated Experts

Jeffrey Sean Healey

Professor, Faculty of Health Sciences

Visit profile

Labels